No Data
Fuan Pharmaceutical (300194.SZ): has the approval for the Against Influenza drug Peramivir injection, but currently does not have production or sales.
On December 23, Gelonghui reported that Fuan Pharmaceutical (300194.SZ) stated on the investor interaction platform that the company has received approval for the anti-influenza drug Peramivir injection, but it is currently not in production or on sale.
Fuan Pharmaceutical (300194.SZ): A subsidiary has withdrawn the pharmaceutical registration application for acetylcysteine injection.
Globe Union reported on December 23 that Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. (hereinafter referred to as "Qingyutang"), recently received a "Notice of Termination of Drug Registration Application" issued by the National Medical Products Administration. The indication for the application of acetylcysteine injection was for the treatment of acetaminophen overdose. Affected by market changes and other factors, after careful research and in conjunction with the company's R&D strategy, the company decided to voluntarily withdraw this registration application.
Fuan Pharmaceutical (300194.SZ): Currently, the products do not include any related to weight loss medications.
Gelong Hui reported on December 23 that Fuan Pharmaceutical (300194.SZ) stated on the investor interaction platform that the company currently does not have any products related to weight loss medications.
Fuan Pharmaceutical (300194.SZ): Some pharmaceuticals from the subsidiary are intended to be selected for national centralized procurement.
On December 13, Gelonghui reported that Fuan Pharmaceutical (300194.SZ) announced that on December 12, 2024, its wholly-owned subsidiary Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. and Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Qingyutang and Tianheng Pharmaceutical") participated in the bidding for the tenth national centralized procurement of Pharmaceuticals organized by the National Organization of Pharmaceuticals Centralized Procurement and Use Joint Procurement Office (hereinafter referred to as "Joint Procurement Office"). After the opening and evaluation of the bids by the Joint Procurement Office, Qingyutang's sodium ampicillin sodium sulbactam (0.75g) and heavy tartrate deoxycorticosterone were assessed.
fuan pharmaceutical (300194.SZ) received pharmaceutical registration certificates for two pharmaceuticals.
fuan pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Qing Yu Tang Pharmaceutical Co., Ltd. (...)
Is Fuan Pharmaceutical (Group) (SZSE:300194) A Risky Investment?
Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
No Data
